Legacy Private Trust Co. Purchases 1,173 Shares of The Procter & Gamble Company (NYSE:PG)

Legacy Private Trust Co. lifted its position in The Procter & Gamble Company (NYSE:PG) by 8.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,801 shares of the company’s stock after acquiring an additional 1,173 shares during the quarter. Legacy Private Trust Co.’s holdings in Procter & Gamble were worth $2,481,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in PG. Geode Capital Management LLC lifted its position in shares of Procter & Gamble by 7.0% in the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares during the period. FMR LLC raised its stake in Procter & Gamble by 2.7% in the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock worth $4,599,554,000 after buying an additional 689,282 shares in the last quarter. Legal & General Group Plc boosted its position in Procter & Gamble by 0.6% during the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after acquiring an additional 122,190 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Procter & Gamble by 10.2% in the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock valued at $3,290,573,000 after acquiring an additional 1,760,214 shares during the period. Finally, Fisher Asset Management LLC raised its position in shares of Procter & Gamble by 4.7% in the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock worth $3,183,522,000 after acquiring an additional 830,476 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PG has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Morgan Stanley raised their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Piper Sandler initiated coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, Evercore ISI raised their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $179.75.

Procter & Gamble Price Performance

Shares of NYSE:PG traded up $0.77 during trading on Wednesday, reaching $162.07. 4,915,484 shares of the company’s stock traded hands, compared to its average volume of 6,550,351. The firm has a market cap of $381.68 billion, a PE ratio of 27.94, a P/E/G ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a 50-day simple moving average of $169.92 and a 200-day simple moving average of $169.75.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the prior year, the company posted $1.83 EPS. The business’s quarterly revenue was down .6% on a year-over-year basis. As a group, analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Insider Activity

In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock worth $13,317,460 over the last 90 days. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.